secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001493152-24-024727
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 1.02, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio receives Nasdaq bid price deficiency notice, repurchases Series B Preferred Stock
--------------------------------------------------------------------------------

- Received Nasdaq letter on June 14, 2024, for non-compliance with $1.00 minimum bid price rule for 35 consecutive business days.
- Company has 180 days until December 11, 2024, to regain compliance by closing bid price at $1.00 or more for 10 consecutive days.
- Repurchased all 3,613 shares of Series B Preferred Stock from SSVK Associates LLC on June 15, 2024, reassuming $3.6 million liabilities.
- Suren Ajjarapu, managing member of SSVK, is a board member; SSVK owns over 5% of common stock.
- Repurchase cancelled all outstanding Series B Preferred Stock; related Assignment and Assumption Agreement terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/0001493152-24-024727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224024727/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-024727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer